NEW YORK (GenomeWeb News) — Caliper Life Sciences today said third-quarter revenues increased 24 percent as R&D spending more than doubled and losses surged 250 percent.
 
Total receipts for the three months ended Sept. 30 increased to $26.5 million from $21.3 million year over year. Most of that revenue came from product sales, which brought in $18.5 million, while services brought in $6 million and licensing and contracts earned $2 million. 
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.